Laura de Magistris

Summary

Affiliation: Second University of Naples
Country: Italy

Publications

  1. ncbi Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity
    Anna Sapone
    Mucosal Biology Research Center, University of Maryland School of Medicine, Baltimore, MD, USA
    BMC Med 9:23. 2011
  2. ncbi Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives
    Laura de Magistris
    Department Magrassi Lanzara, Gastroenterology, Second University of Naples, Italy
    J Pediatr Gastroenterol Nutr 51:418-24. 2010
  3. ncbi Assessment of intestinal permeability and orocecal transit time in patients with systemic sclerosis: analysis of relationships with epidemiologic and clinical parameters
    Luigi Caserta
    Gastroenterology Unit, Magrassi-Lanzara Department of Clinical and Experimental Internal Medicine, Second University of Naples, Naples, Italy
    Rheumatol Int 23:226-30. 2003
  4. ncbi Cellobiose and lactulose coupled with mannitol and determined using ion-exchange chromatography with pulsed amperometric detection, are reliable probes for investigation of intestinal permeability
    Maddalena Generoso
    Department of Experimental Medicine, School of Medicine, Second University of Naples, Via De Crecchio 8, 80138, Naples, Italy
    J Chromatogr B Analyt Technol Biomed Life Sci 783:349-57. 2003
  5. ncbi The expression of caspases is enhanced in peripheral blood mononuclear cells of autism spectrum disorder patients
    Dario Siniscalco
    Department of Experimental Medicine, Division of Pharmacology, Second University of Naples, via S Maria di Costantinopoli 16, 80138 Naples, Italy
    J Autism Dev Disord 42:1403-10. 2012

Collaborators

Detail Information

Publications5

  1. ncbi Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity
    Anna Sapone
    Mucosal Biology Research Center, University of Maryland School of Medicine, Baltimore, MD, USA
    BMC Med 9:23. 2011
    ....
  2. ncbi Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives
    Laura de Magistris
    Department Magrassi Lanzara, Gastroenterology, Second University of Naples, Italy
    J Pediatr Gastroenterol Nutr 51:418-24. 2010
    ..Faecal calprotectin (FC) was also measured in patients with autism, either with or without gastrointestinal symptoms, and in their first-degree relatives...
  3. ncbi Assessment of intestinal permeability and orocecal transit time in patients with systemic sclerosis: analysis of relationships with epidemiologic and clinical parameters
    Luigi Caserta
    Gastroenterology Unit, Magrassi-Lanzara Department of Clinical and Experimental Internal Medicine, Second University of Naples, Naples, Italy
    Rheumatol Int 23:226-30. 2003
    ....
  4. ncbi Cellobiose and lactulose coupled with mannitol and determined using ion-exchange chromatography with pulsed amperometric detection, are reliable probes for investigation of intestinal permeability
    Maddalena Generoso
    Department of Experimental Medicine, School of Medicine, Second University of Naples, Via De Crecchio 8, 80138, Naples, Italy
    J Chromatogr B Analyt Technol Biomed Life Sci 783:349-57. 2003
    ..0714). Ce/Ma and/or La/Ma tests result similarly reliable in the clinical investigation of IP and the described new method is also helpful in urine even with high glucose concentration, without any interference...
  5. ncbi The expression of caspases is enhanced in peripheral blood mononuclear cells of autism spectrum disorder patients
    Dario Siniscalco
    Department of Experimental Medicine, Division of Pharmacology, Second University of Naples, via S Maria di Costantinopoli 16, 80138 Naples, Italy
    J Autism Dev Disord 42:1403-10. 2012
    ..Our data are suggestive of a possible role of the caspase pathway in ASD clinical outcome and of the use of caspase as potential diagnostic and/or therapeutic tools in ASD management...